Physician
Pain Evaluation & Management Center of Ohio, INC.
Pain Evaluation & Management Center of Ohio, INC. was paid $914K by Medicaid between Jan 2018 and Nov 2024, across 42 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 37% of everything it billed.
33Billing provider infoPAIN EVALUATION & MANAGEMENT CENTER OF OHIO, INC.
CENTERVILLE, OH 45458
CENTERVILLE, OH 45458
33aNPI1811940182assigned 05/18/2006
33bProvider typeFamily Medicine Physician
28Total paid$914K
24GClaims34,276
24DCodes billed42
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Family Medicine Physician providers in Ohio
Rank by total paid#72 of 739
Median peer was paid$30K
This provider vs. median31×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,560 | $39K | |
| 2019 | 2,697 | $39K | |
| 2020 | 5,308 | $81K | |
| 2021 | 5,899 | $154K | |
| 2022 | 7,182 | $245K | |
| 2023 | 5,355 | $205K | |
| 2024incomplete | 4,275 | $150K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 37% | 10,097 | 9,257 | $335K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 14,813 | 13,697 | $300K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 14% | 991 | 930 | $124K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 10% | 2,441 | 2,292 | $93K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.0% | 250 | 244 | $18K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 601 | 235 | $8K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 33 | 31 | $5K |
| E0730 | Transcutaneous electrical nerve stimulation (tens) device, four or more leads, for multiple nerve stimulation | <1% | 14 | 12 | $2K |
| 80346 | <1% | 107 | 105 | $2K | |
| 01992 | <1% | 54 | 40 | $2K | |
| 80363 | <1% | 107 | 105 | $2K | |
| 80361 | <1% | 107 | 105 | $2K |
30 more codes
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 99 | $2K |
| 83992 | <1% | 107 | $1K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 26 | $1K |
| 80349 | <1% | 107 | $1K | |
| 80353 | <1% | 107 | $1K | |
| 80358 | <1% | 107 | $1K | |
| 80359 | <1% | 107 | $1K | |
| 80354 | <1% | 107 | $1K | |
| 80365 | <1% | 107 | $1K | |
| 80373 | <1% | 107 | $1K | |
| 80372 | <1% | 107 | $1K | |
| 80348 | <1% | 107 | $1K | |
| 80355 | <1% | 107 | $1K | |
| 80356 | <1% | 107 | $1K | |
| 80366 | <1% | 107 | $1K | |
| 80325 | <1% | 105 | $983.10 | |
| 62370 | <1% | 42 | $862.52 | |
| 76942 | <1% | 26 | $606.69 | |
| 80345 | <1% | 53 | $483.32 | |
| 80336 | <1% | 53 | $483.32 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 162 | $455.68 |
| 80323 | <1% | 53 | $453.34 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 29 | $277.73 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 62 | $238.34 |
| A4649 | Surgical supply; miscellaneous | <1% | 1,369 | $185.66 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 140 | $130.61 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 277 | $129.51 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 298 | $20.00 |
| A4215 | Needle, sterile, any size, each | 0% | 413 | $0.00 |
| A4550 | Surgical trays | 0% | 63 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDONNINI, RICHARD (CO-OWNER)